Quantbot Technologies LP Biomarin Pharmaceutical Inc Transaction History

Quantbot Technologies LP

$3.24 Billion
Q3 2025

A detailed history of Quantbot Technologies LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Quantbot Technologies LP holds 9,082 shares of BMRN stock, worth $497,057. This represents 0.02% of its overall portfolio holdings.

Number of Shares

9,082

Previous 670 1255.52%

Holding current value

$497,057

Previous $36,000 1263.89%

% of portfolio

0.02%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$52.62 - $61.93 $442,639 - $520,955	8,412 Added 1255.52%	9,082 $491,000
Q2 2025 Aug 13, 2025	SELL	$54.08 - $68.32 $398,785 - $503,791	-7,374 Reduced 91.67%	670 $36,000
Q1 2025 May 13, 2025	BUY	$61.25 - $72.83 $338,896 - $402,968	5,533 Added 220.35%	8,044 $568,000
Q4 2024 Feb 11, 2025	BUY	$61.93 - $70.49 $5,202 - $5,921	84 Added 3.46%	2,511 $165,000
Q3 2024 Nov 13, 2024	BUY	$69.02 - $93.84 $167,511 - $227,749	2,427 New	2,427 $170,000

Q2 2023 Aug 08, 2023	BUY	$86.68 - $100.3 $267,061 - $309,024	3,081 New	3,081 $267,000
Q3 2022 Nov 07, 2022	BUY	$82.16 - $96.94 $1.49 Million - $1.76 Million	18,175 Added 528.8%	21,612 $1.83 Million
Q2 2022 Aug 09, 2022	SELL	$71.48 - $86.85 $25,375 - $30,831	-355 Reduced 9.36%	3,437 $284,000
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $92,478 - $115,399	1,245 Added 48.88%	3,792 $292,000
Q4 2021 Feb 11, 2022	SELL	$71.72 - $91.47 $138,634 - $176,811	-1,933 Reduced 43.15%	2,547 $225,000
Q3 2021 Nov 09, 2021	BUY	$74.77 - $85.47 $334,969 - $382,905	4,480 New	4,480 $346,000
Q2 2021 Aug 12, 2021	SELL	$75.51 - $84.79 $638,437 - $716,899	-8,455 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $631,842 - $766,783	8,455 New	8,455 $638,000
Q4 2020 Feb 12, 2021	SELL	$72.61 - $90.2 $1.23 Million - $1.53 Million	-16,964 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $1.22 Million - $2.22 Million	16,964 New	16,964 $1.29 Million
Q4 2019 Feb 10, 2020	SELL	$64.27 - $86.37 $427,202 - $574,101	-6,647 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$67.4 - $85.11 $230,845 - $291,501	3,425 Added 106.3%	6,647 $448,000
Q2 2019 Aug 13, 2019	SELL	$80.35 - $93.9 $617,891 - $722,091	-7,690 Reduced 70.47%	3,222 $275,000
Q1 2019 May 13, 2019	BUY	$84.2 - $98.62 $918,790 - $1.08 Million	10,912 New	10,912 $969,000
Q4 2018 Feb 13, 2019	SELL	$80.14 - $106.07 $3.06 Million - $4.05 Million	-38,170 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$93.92 - $105.72 $3.58 Million - $4.04 Million	38,170 New	38,170 $3.7 Million
Q4 2017 Feb 12, 2018	SELL	$80.76 - $95.13 $228,793 - $269,503	-2,833 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$80.6 - $94.95 $228,339 - $268,993	2,833	2,833 $263,000

Others Institutions Holding BMRN

# of Institutions

667

Shares Held

182M

Call Options Held

1.48M

Put Options Held

957K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Account

Quantbot Technologies LP Biomarin Pharmaceutical Inc Transaction History